Press Releases from Intas Biopharmaceuticals Limited (6 total)
Intas Biopharmaceuticals win GOLD award for Quality Excellence
Ahmedabad, January 27, 2010: Intas Biopharmaceuticals Limited, India’s premier biopharmaceutical organization, has received GOLD Award for Quality Excellence in the category of Formulations Unit. The…
Awareness for “Growth Factors” in India: A social initiative of Intas Biopha …
Cancer, being one of the most dreadful diseases in recent times, has generated a necessity to increase the awareness in the society and medical fraternity.…
INTAS BIOPHARMACEUTICALS ACQUIRES US–BASED BPD INC
India’s leading biopharmaceutical company, Intas Biopharmaceuticals Limited (IBPL) has acquired US-based biotechnology corporation, Biologics Process Development Incorporated (BPD Inc.), based in Poway, California. With acquisition…
Intas Biopharma to market lung cancer drug GEFITINIB in India
Intas Biopharmaceuticals Limited is all set to market Lung Cancer drug, GEFITINIB, under brand name “GEFFY”, in Indian market. In line with company’s sales strategy…
Intas plans Filgrastim launch in North America, Europe
Intas Biopharma is a part of Cooperation between three continents for Biosimilar GCSF
Ahmedabad, May 5, 2008: INTAS BIOPHARMACEUTICALS LIMITED (IBPL) signed business agreement with Canada–based…
INTAS BIOPHARMA & KWIZDA COMPLETE PHASE I CLINICAL TRIAL OF NEUKINE® IN EUROPE
Intas Biopharmaceuticals Limited (IBPL) and European pharmaceutical major Kwizda Pharma GmbH has jointly completed Phase I clinical trial study of NEUKINE®, biosimilar form of recombinant…
Go To Page:
